HRS cells also modulate their interactions with CD4+ T cells by expressing surface molecules such as CD80 and CD40, which engage with immune cells to provide survival signals while simultaneously shielding the tumor from effective immune attack [35]. The gene discussed is CD40; the disease is neoplasm.